Direct oral anticoagulants in antiphospholipid syndrome
Main Authors: | Jozélio Freire de Carvalho, Daniele Castro Oliveira de Andrade, Roger A. Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Reumatologia
|
Series: | Revista Brasileira de Reumatologia |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000600469&lng=en&tlng=en |
Similar Items
-
Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01) -
Antiphospholipid Syndrome Committee of the Brazilian Society of Rheumatology position statement on the use of direct oral anticoagulants (DOACs) in antiphospholipid syndrome (APS)
by: Gustavo Guimarães Moreira Balbi, et al.
Published: (2020-05-01) -
NEW ORAL ANTICOAGULANTS IN THE THERAPY OF ANTIPHOSPHOLIPID SYNDROME
by: M. A. Satybaldyeva, et al.
Published: (2016-07-01) -
Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
by: Daniele Pastori, et al.
Published: (2021-08-01) -
Síndrome antifosfolípide primária e infecções por hepatites B e C Primary antiphospholipid syndrome and hepatitis B and C infections
by: Jozélio Freire de Carvalho
Published: (2009-10-01)